Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Longitudinal changes in quality of life and related psychosocial variables in australians with multiple sclerosis.
Should MRI be the primary endpoint of phase 3 trials in multiple sclerosis?
Cortical Damage and Disability in Multiple Sclerosis: Relation to Intracortical Inhibition and Facilitation.
Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb.
The role of dopamine in modulation of Th-17 immune response in multiple sclerosis.
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial.
Social Cognitive Predictors of Physical Activity in Relapsing-Remitting Multiple Sclerosis.
Focal MMP-2 and MMP-9 Activity at the Blood-Brain Barrier Promotes Chemokine-Induced Leukocyte Migration.
Development of the Oxford Participation and Activities Questionnaire: constructing an item pool.
Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis.
Brachial plexus atrophy in chronic inflammatory demyelinating polyradiculoneuropathy.
Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis - insights into possible drug mechanism.
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
Care patterns in multiple sclerosis: principal care, comprehensive team care, consortium care.
A report from the American Academy of Neurology 2014 Annual Meeting (April 26-May 3 - Philadelphia, Pennsylvania, USA).
Quality of life among people with multiple sclerosis: Replication of a three-factor prediction model.
MUNDUS project: MUltimodal Neuroprosthesis for daily Upper limb Support.
[Treatment for multiple sclerosis in patients with collagen diseases].
Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.
Idiopathic acute transverse myelitis: Complete recovery after intravenous immunoglobulin.
The pathological and physiological roles of IL-6 amplifier activation.
Regulatory B Cells and Mechanisms.
Citrullination of TNF-α by peptidylarginine deiminases reduces its capacity to stimulate the production of inflammatory chemokines.
Pages
« first
‹ previous
…
571
572
573
574
575
576
577
578
579
…
next ›
last »